Skip to main content
Journal cover image

Treatment of myasthenia gravis: current practice and future directions.

Publication ,  Journal Article
Ciafaloni, E; Sanders, DB
Published in: Expert Rev Neurother
September 2002

Myasthenia gravis is the best understood of the autoimmune diseases and a number of treatments are currently used to produce clinical improvement. However, due to the scarcity of evidence-based and comparative data, there is still no consensus on many therapeutic issues. Even a widely accepted treatment like thymectomy has never been proven effective by a well-designed trial. These are just some of the unanswered questions: What is the best treatment algorithm and safest long-term management of myasthenia gravis? What patients are likely to benefit from thymectomy? How long should myasthenia gravis patients be treated? Is it possible to discontinue immunotherapy once remission has been achieved? What are the risks associated with long-term immunosuppression? In this article, we review current therapeutic strategies and these unresolved questions about myasthenia gravis treatment.

Duke Scholars

Published In

Expert Rev Neurother

DOI

EISSN

1744-8360

Publication Date

September 2002

Volume

2

Issue

5

Start / End Page

743 / 748

Location

England

Related Subject Headings

  • Neurology & Neurosurgery
  • 3214 Pharmacology and pharmaceutical sciences
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ciafaloni, E., & Sanders, D. B. (2002). Treatment of myasthenia gravis: current practice and future directions. Expert Rev Neurother, 2(5), 743–748. https://doi.org/10.1586/14737175.2.5.743
Ciafaloni, Emma, and Donald B. Sanders. “Treatment of myasthenia gravis: current practice and future directions.Expert Rev Neurother 2, no. 5 (September 2002): 743–48. https://doi.org/10.1586/14737175.2.5.743.
Ciafaloni E, Sanders DB. Treatment of myasthenia gravis: current practice and future directions. Expert Rev Neurother. 2002 Sep;2(5):743–8.
Ciafaloni, Emma, and Donald B. Sanders. “Treatment of myasthenia gravis: current practice and future directions.Expert Rev Neurother, vol. 2, no. 5, Sept. 2002, pp. 743–48. Pubmed, doi:10.1586/14737175.2.5.743.
Ciafaloni E, Sanders DB. Treatment of myasthenia gravis: current practice and future directions. Expert Rev Neurother. 2002 Sep;2(5):743–748.
Journal cover image

Published In

Expert Rev Neurother

DOI

EISSN

1744-8360

Publication Date

September 2002

Volume

2

Issue

5

Start / End Page

743 / 748

Location

England

Related Subject Headings

  • Neurology & Neurosurgery
  • 3214 Pharmacology and pharmaceutical sciences
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1109 Neurosciences